Navigation Links
BioHorizons Expands to New 44,000 Square Foot Facility
Date:12/7/2007

BIRMINGHAM, Ala., Dec. 7 /PRNewswire/ -- BioHorizons Implant Systems, Inc. relocated its global headquarters in Birmingham, Alabama, to a state-of-the- art, 44,000 square foot facility. The new facility, located at 2300 Riverchase Center, houses all administrative services, a newly formed manufacturing facility and a distribution center. The manufacturing facility will include machining, surface treatment and packaging services.

The new facility was required due to tremendous growth and an expanding product offering. BioHorizons' President and CEO Steve Boggan commented, "We have experienced revenue growth of over 25% for each of the last six years and expect this growth rate to continue over the next several years. As a result, a new facility was required to house our expanding administrative and operations team. Further, the expanded facility allows for vertical integration of our product line to realize margin improvement and manufacturing efficiencies." He continued by stating, "Having manufacturing in-house will also allow us to be even more responsive to the needs of our customers."

About BioHorizons

BioHorizons was founded in 1994 as an incubator company at the University of Alabama at Birmingham. BioHorizons' flagship External Implant System, a patented system of dental implants and related products, was launched in 1997. BioHorizons has a strong product offering of dental implants including internal hex, external hex, straight-walled, tapered, overdenture and one-piece implants. BioHorizons has signed exclusive distribution agreements with LifeCell Corp. and Osteotech, Inc. to market their allograft regeneration products to the dental community. With 217 employees, BioHorizons has grown into one of the largest dental implant companies in the world. The company has a direct sales force in the U.S., Canada, Germany, Spain and United Kingdom. Products are distributed in the rest of the world via a network of independent distributors. The Company was purchased by HealthpointCapital in 2006.

http://www.biohorizons.com

About HealthpointCapital

HealthpointCapital is a values-driven, research-based private equity firm exclusively focused on the musculoskeletal sector - specifically orthopedics and dental.

With a cumulative 85 years of experience in healthcare technology, research and private investing, HealthpointCapital helps clients capitalize on the explosive growth and unique investment opportunities in one of the fastest growing sectors of the medical device industry.
HealthpointCapital manages $650 million of institutional capital.

http://www.healthpointcapital.com

For more information, contact:

Greg Bryant

866.872.9785


'/>"/>
SOURCE HealthpointCapital
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. BioHorizons Introduces Its New Tapered Internal Implants Featuring Laser-Lok(R) Microgrooves
2. Longaberger Expands Horizon of Hope Campaign to Build Support for American Cancer Societys Breast Cancer Initiatives
3. Rohm and Haas Expands in India
4. US Med-Equip Expands Corporate Support Center
5. Concentra Expands Horizon Air Employee Health Program With On-Site Clinic
6. Regional Center of Orange County Expands Family Support Resources to Meet Growing Needs
7. Maimonides Expands Circulation of Physicians Practice Journal to Staten Island Doctors
8. Specialty Blades, Inc. Expands Management Team With New VP Engineering
9. CRH Medical expands Las Vegas operations
10. ISTA Pharmaceuticals Expands Its Pipeline in Allergy Treatments
11. Bipartisan Bill Expands Health Care Access for Small Businesses
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2017)... (PRWEB) , ... April 29, 2017 , ... Phytomer USA ... As a Phytomer Account Manager, Smith’s role is to provide excellent customer ... that make up The Phytomer Group. Smith comes to Phytomer with a wealth of ...
(Date:4/28/2017)... ... April 28, 2017 , ... The National Campaign to ... the Access to Contraception for Women Servicemembers and Dependents Act of 2017. The ... will help to ensure that all members of the Armed Forces receive high ...
(Date:4/28/2017)... ... April 28, 2017 , ... Horizon Blue Cross Blue Shield of New Jersey ... “A” and its outlook as “stable.” At the same time, the ratings agency cautioned ... recent years, dip below “capital adequacy” thresholds required for its strong rating. , “Horizon ...
(Date:4/28/2017)... ... April 28, 2017 , ... The Radiology Business Management ... officers for 2017-2018. The annual board election process has been in place since the ... , Thomas C. Dickerson, Ed.D., FACHE, succeeds Jim Hamilton, MHA, CMM, FRBMA, as president. ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... liability could substantially improve drug safety and minimize the cost of development. In ... ion channel inhibition using cell lines and for cardiac toxicity using induced pluripotent ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... 19, 2017  Novartis today announced the publication ... Lung, and Blood Institute (NHLBI) of the National ... patients with treatment-naïve severe aplastic anemia (SAA) achieved ... eltrombopag at the initiation of and concurrently with ... three sequential treatment groups, or cohorts. Cohort 3 ...
(Date:4/18/2017)... MINNEAPOLIS , April 18, 2017 Cogentix ... focused on providing the Urology, Uro/Gyn and Gynecology markets ... for the first quarter ended March 31, 2017 after ... The Company will host a conference call ... day on Tuesday, May 2, 2017 at 4:30 p.m. ...
(Date:4/18/2017)... , April 18, 2017  Astute Medical, Inc., developer ... series to be presented at the 2017 National Kidney ... today and continues through April 22. Physicians will present ... used to assess risk for acute kidney injury (AKI) ... failure (ADHF). Elevated levels of TIMP-2 ...
Breaking Medicine Technology: